TFRC and chronic myelogenous leukemia, BCR-ABL1 positive: Further, the specificity of drug delivery can be increased by coating drug-loaded liposomes with ligands targeting specific cell surface markers, like transferrin receptor (TfR), whose expression is increased in CML cells.